Advertisement

Related Videos

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Welcome and Introduction to Vi3C

Varsha Gandhi, PhD, on Ibrutinib

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Advertisement

Advertisement




Mar
05
Today In Oncology
Black Patients With AML Face Younger Onset and Significantly Worse Survival Outcomes
CD123-Targeting ADC Shows Activity in AML and BPDCN
Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds
Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence
Research Suggests AI Pathology Models May Take Unreliable Shortcuts to Identify Cancer Biomarkers
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo